What are the guidelines for using home narrow-band Ultraviolet B (UVB) therapy in patients with psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Home Narrow-band UVB Therapy in Psoriasis

Home narrow-band UVB (NB-UVB) phototherapy is an effective and appropriate maintenance option for psoriasis patients who have achieved clearance with in-office phototherapy but face logistical challenges with continued clinic visits. 1

Indications for NB-UVB Therapy

  • First-line phototherapy option for moderate to severe plaque and guttate psoriasis 1
  • Appropriate for patients with:
    • Significant body surface area involvement (typically >5% BSA)
    • Psoriasis not adequately controlled with topical treatments
    • Need for a treatment option that avoids systemic immunosuppression

Advantages of NB-UVB over PUVA

  • Lower long-term photocarcinogenic risk
  • No need for oral medication before treatments
  • No need for photoprotective eyewear between treatments
  • Safe to use during pregnancy 1
  • Avoids drug interactions and systemic side effects

Home vs. Office-Based NB-UVB

When to Consider Home NB-UVB

Home NB-UVB is particularly valuable for:

  • Patients who have achieved clearance with in-office therapy and need maintenance
  • Those who are geographically isolated from phototherapy centers
  • Patients unable to attend 2-3 weekly in-office sessions due to work or other commitments 1
  • Patients with stable disease who understand proper usage protocols

Safety Considerations for Home NB-UVB

  • Patient education is essential before initiating home therapy 1
  • Equipment must be certified with accurate dosimetry systems 2
  • Patients should receive proper training on:
    • Operating the equipment
    • Recognizing and managing side effects
    • Appropriate eye protection during treatments
    • Proper skin protection for areas not requiring treatment 3

Treatment Protocol for NB-UVB

Initial Treatment Phase

  • Starting doses should be based on skin type:

    • Skin type II: 180-200 mJ/cm²
    • Skin type III: 200-250 mJ/cm²
    • Skin type IV: 250-300 mJ/cm²
    • Skin type V-VI: 300-400 mJ/cm² 4
  • Frequency: 3 times per week is optimal for clearing (higher clearance rates of 62% vs. 17% with <2 sessions/week) 4, 5

  • Duration: Typically requires 20-30 treatments for significant improvement 1

Dose Increments

  • Fixed increments based on skin type are safer than percentage-based increases:
    • Skin type II: 30 mJ/cm²
    • Skin type III: 40 mJ/cm²
    • Skin type IV: 50 mJ/cm²
    • Skin type V-VI: 60-150 mJ/cm² 4

Maintenance Phase

  • Once clearance is achieved, frequency can be reduced to 1-2 times weekly
  • No strong evidence supports continuous maintenance therapy, but it may be considered for quickly recurrent disease 1
  • The goal is to use the lowest effective dose with the least toxic therapy 1

Monitoring and Safety

  • Patients should be monitored for:

    • Erythema (redness)
    • Burning
    • Itching
    • Long-term skin changes
  • Sun protection recommendations:

    • Use physical sunscreens with zinc oxide/titanium dioxide (SPF 30-50+)
    • Apply sunscreen to areas not requiring treatment
    • Avoid photosensitizing medications when possible 3
  • Long-term monitoring:

    • Annual skin examinations recommended for patients receiving >150 phototherapy sessions 2
    • Consider setting a lifetime maximum of 250 NB-UVB sessions (similar to PUVA guidelines) 2

Combination Therapies

  • NB-UVB can be combined with:
    • Topical corticosteroids
    • Vitamin D analogs (though synergistic effects are less pronounced)
    • Retinoids (acitretin) - can enhance efficacy and reduce required UV exposure 1, 2

Efficacy Expectations

  • 60-90% of patients achieve complete or near-complete clearance within 20-40 sessions 2
  • NB-UVB leads to approximately 25% reduction in steroid cream use and 30% reduction in vitamin-D product use for up to 12 months following treatment 6
  • Better results are typically seen with guttate and nummular psoriasis compared to large plaque psoriasis 2

Contraindications and Cautions

  • History of melanoma or multiple non-melanoma skin cancers
  • Photosensitizing medications
  • Photosensitive disorders
  • History of arsenic exposure or ionizing radiation
  • Inability to follow safety protocols

Home NB-UVB therapy represents an effective, convenient option for appropriate psoriasis patients, offering similar efficacy to in-office treatment while improving treatment adherence through greater accessibility.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.